AN2 Therapeutics, Inc. (ANTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 87.49M | 59.94M | 64.02M | 67.52M | 69.56M | 86.26M | 97.69M | 107.44M | 116.31M | 110.51M | 126.41M | 98.21M |
| Cash & Short-Term Investments | 85.29M | 58M | 61.92M | 62.92M | 67.06M | 83.62M | 93.43M | 104.54M | 114.21M | 107.3M | 123.82M | 95.26M |
| Cash Only | 53.49M | 19.94M | 18M | 18.22M | 19.98M | 21.35M | 33.5M | 26.77M | 24.69M | 15.65M | 32.62M | 40.81M |
| Short-Term Investments | 31.8M | 38.06M | 43.92M | 44.7M | 47.08M | 62.27M | 59.92M | 77.77M | 89.52M | 91.65M | 91.2M | 54.45M |
| Accounts Receivable | 0 | 900K | 400K | 2.7M | 0 | 300K | 1M | 300K | 0 | 1.4M | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.2M | 1.04M | 1.7M | 1.91M | 300K | 2.34M | 3.26M | 2.6M | 0 | 0 | 2.59M | 13K |
| Total Non-Current Assets | 0 | 2.01M | 3.22M | 8.3M | 11.78M | 5.83M | 0 | 1.04M | 4.95M | 28.24M | 27.4M | 720K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 2.01M | 3.22M | 8.3M | 11.48M | 5.02M | 0 | 0 | 3.9M | 27.19M | 26.36M | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 304K | 804K | 0 | 1.04M | 1.04M | 1.04M | 1.04M | 720K |
| Total Assets | 87.49M | 61.95M | 67.23M | 75.83M | 81.34M | 92.09M | 97.69M | 108.48M | 121.26M | 138.74M | 153.81M | 98.93M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 7.56% | -32.73% | -31.17% | -30.1% | -32.92% | -33.63% | -36.49% | 9.66% | 33.13% | 35.28% | 39.82% | -17.57% |
| Total Current Liabilities | 5.56M | 8.72M | 2.23M | 2.11M | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M | 14.04M | 14.84M | 11.16M |
| Accounts Payable | 2.62M | 3.02M | 2.23M | 2.11M | 3.07M | 3.32M | 1.71M | 1.89M | 2.43M | 2.68M | 4.88M | 3.13M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.95M | 5.7M | 0 | -1.2M | 369K | 2.47M | 3.38M | 6.4M | 321K | 668K | 976K | 195K |
| Current Ratio | 15.73x | 6.87x | 28.76x | 31.96x | 8.68x | 8.43x | 9.75x | 10.61x | 10.91x | 7.87x | 8.52x | 8.80x |
| Quick Ratio | 15.73x | 6.87x | 28.76x | 31.96x | 8.68x | 8.43x | 9.75x | 10.61x | 10.91x | 7.87x | 8.52x | 8.80x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 170K | 170K | 4.63M | 4.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 170K | 170K | 4.63M | 4.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |
| Total Liabilities | 5.73M | 8.89M | 6.86M | 6.98M | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M | 14.04M | 14.84M | 11.16M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K |
| Net Debt | -53.49M | -19.94M | -18M | -18.22M | -19.98M | -21.35M | -33.5M | -26.77M | -24.69M | -15.65M | -32.62M | -40.8M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -2372.33x | - | -2.81x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 81.76M | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M | 87.67M | 98.35M | 110.6M | 124.7M | 138.97M | 87.76M |
| Equity Growth % | 11.5% | -35.17% | -31.13% | -30.01% | -33.7% | -34.36% | -36.91% | 12.07% | 34.03% | 30.75% | 31.63% | -24.25% |
| Book Value per Share | 2.40 | 1.76 | 1.99 | 2.28 | 2.44 | 2.74 | 2.94 | 3.30 | 3.72 | 4.19 | 5.42 | 4.50 |
| Total Shareholders' Equity | 81.76M | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M | 87.67M | 98.35M | 110.6M | 124.7M | 138.97M | 87.76M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -250.98M | -240.95M | -232.24M | -222.89M | -216.43M | -205.78M | -198.25M | -185.51M | -171.07M | -154.46M | -137.56M | -120.85M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5K | 57K | 64K | 25K | 48K | 31K | 112K | -27K | 53K | 275K | -122K | -119K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |